Fig. 1 · Structure

Documents & Downloads

Mianserin hydrochloride

Cat. No. A10588 CAS 21535-47-7

5-HT2/5-HT1 antagonist

Mianserin hydrochloride is a 5-HT2/5-HT1 antagonist. Has moderate affinity for 5-ht6 Non-selective 5-HT2 receptor antagonist. Has moderate affinity for 5-HT6. Antidepressant.

In Stock

Free Aliquoting for Your Order

Tell us your preferred amount per vial. We’ll confirm the options.

Biological Activity

Target & Activity

Target Activity Value
Histamine receptor

In Vivo Studies

In worms, Mianserin hydrochloride attenuated age-associated transcriptional changes in the comparison between age-matched treated and untreated controls within a design that also included FUDR. In another worm study whose design also included FUDR, Mianserin hydrochloride fully induced the xenobiotic response relative to water-treated controls irrespective of the treatment start time examined. In adult male crickets given Mianserin before recall testing, preference for the unpunished control odor increased significantly after aversive conditioning and reached levels as high as those in saline-injected controls. In fly brains, the octopamine-evoked intracellular calcium response was significantly decreased with octopamine plus Mianserin compared with octopamine alone. [1,2,3]

Literature-reported observations and conditions; not Adooq-tested protocols or general treatment recommendations.

Mianserin and age-associated transcriptional changes in worms

Animal study · N2 worms [1]

Animals in cohort #1 were treated on day 1 with water (solvent) or 50 µM mianserin, and harvested on day 3, 5, and 10 of adulthood. Mianserin treatment attenuates age-associated gene expression changes preserving expression levels as seen in young adults. Initiating mianserin treatment at later ages reduces (d3) or abolishes (d5) its effect on transcriptional drift.

Measured endpoints — not treatment concentrations
EndpointReported resultReference
Mianserin-induced changes in transcription were determined by RNA-seq.age-associated changes in transcription 15,095 out of 19,169 genes (80%)[1]

Conditions shared by the study groups

Treatment course
treated on day 1 with water (solvent) or 50 µM mianserin, and harvested on day 3, 5, and 10 of adulthood
Vehicle
water (solvent)
Study groups and reported outcomes
Group / doseComparatorObserved resultReference
Mianserin hydrochloride 50 µMwater (solvent)Animals in cohort #1 were treated on day 1 with water (solvent) or 50 µM mianserin, and harvested on day 3, 5, and 10 of adulthood. Mianserin treatment attenuated age-associated changes in transcription in 15,095 out of 19,169 genes (80%, binomial P < 10–100).[1]
Mianserin hydrochloride 50 µM
Model: N2 worms
Reported limits: Not stated in the sentences used: route.
Methods and source locations

Compound reported in the paper: Mianserin hydrochloride; Compound label in the paper: Mianserin

Literature evidence for the named compound in the stated model; no Adooq product-use or lot-performance claim.

Results > Aging causes a loss of co-expression patterns observed in young adults (S5, S28); Materials and methods > RNA-sequencing (RNA-seq) transcriptional studies and data analysis (S292, S294, S295); Figure 2—figure supplement 2. legend (S406)

Mianserin-induced changes in transcription were determined by RNA-seq.: Mianserin-induced changes in transcription were determined by RNA-seq.; comparator: water (solvent) — Results > Aging causes a loss of co-expression patterns observed in young adults (S28); Materials and methods > RNA-sequencing (RNA-seq) transcriptional studies and data analysis (S292, S295)

Mianserin hydrochloride 50 µM · Results > Aging causes a loss of co-expression patterns observed in young adults (S28); Materials and methods > RNA-sequencing (RNA-seq) transcriptional studies and data analysis (S295)

Mianserin and aversive olfactory memory recall in crickets

Animal study · Adult male crickets, G. bimaculatus, at 1 week after the imaginal molt [2]

The effects of OA receptor antagonists on the recall of aversive olfactory memory were studied. The groups injected with epinastine and mianserin exhibited significantly increased preferences for the control odor, the levels of preferences being as high as that of the saline-injected control group. Thus, OA receptor antagonists do not impair aversive memory recall.

Measured endpoints — not treatment concentrations
EndpointReported resultReference
unpunished control odorReported result Six-trial aversive olfactory conditioning trials; on the next day, 3 μl of saline containing 1 μM mianserin at 30 min before the final test. Significantly increased preferences for the control odor before and after conditioning, the levels of preferences being as high as that of the saline-injected control group. Thus, OA receptor antagonists do not impair aversive memory recall.[2]

Conditions shared by the study groups

Route
into the head hemolymph
Treatment course
One day later; at 30 min after injection
Vehicle
saline
Study groups and reported outcomes
Group / doseComparatorObserved resultReference
Mianserin 1 μMbefore and after conditioning; between experimental and saline-injected control groupsSix-trial aversive olfactory conditioning trials; on the next day, 3 μl of saline containing 1 μM mianserin at 30 min before the final test. Significantly increased preferences for the control odor before and after conditioning, the levels of preferences being as high as that of the saline-injected control group. Thus, OA receptor antagonists do not impair aversive memory recall.[2]
Mianserin 1 μM
Model: Adult male crickets, G. bimaculatus, at 1 week after the imaginal molt
Methods and source locations

Compound reported in the paper: Mianserin

The paper names Mianserin without stating the salt or form; not verified as the hydrochloride form supplied as A10588. No dose conversion or lot validation.

Results > OA and DA receptor antagonists impair the recall of appetitive and aversive olfactory memory, respectively (S16, S17, S18, S19); Methods > Insects (S145, S146); Methods > Olfactory conditioning procedure (S148); Methods > Pharmacology (S192); Figure 1 legend (S206, S207, S208, S210)

unpunished control odor: unpunished control odor; comparator: before and after conditioning; between experimental and saline-injected control groups — Results > OA and DA receptor antagonists impair the recall of appetitive and aversive olfactory memory, respectively (S18, S19); Figure 1 legend (S206, S207, S208, S210)

Mianserin 1 μM · Results > OA and DA receptor antagonists impair the recall of appetitive and aversive olfactory memory, respectively (S17, S18, S19); Methods > Pharmacology (S192); Figure 1 legend (S206, S207, S210)

Mianserin and octopamine-evoked calcium responses in fly brains

Animal study · Up to 7 day old uas-GCaMP3.0;0104-GAL4 flies; each n = 11 flies [3]

Fly brains received bath-applied Mianserin, and intracellular calcium responses were measured. The octopamine-evoked response was significantly decreased with octopamine plus mianserin compared with octopamine alone.

Measured endpoints — not treatment concentrations
EndpointReported resultReference
intracellular Ca2+, measured using GCaMP3.0, in 0104-DA neuronsReported result OA-evoked response (red trace) is significantly decreased in brains treated with 2.45 mM mianserin[3]

Conditions shared by the study groups

Route
added to the bath
Treatment course
The spontaneous baseline GCaMP3.0 response was imaged for 30 s; After another 30 s
Vehicle
sugar-free HL3-like saline
Study groups and reported outcomes
Group / doseComparatorObserved resultReference
Mianserin 2.45 mM5 mM OA; OA-evoked response (red trace)OA-evoked response (red trace) is significantly decreased in brains treated with 2.45 mM mianserin[3]
Mianserin 2.45 mM
Model: Up to 7 day old uas-GCaMP3.0;0104-GAL4 flies; each n = 11 flies
Methods and source locations

Compound reported in the paper: Mianserin

The paper names Mianserin without stating the salt or form; not verified as the hydrochloride form supplied as A10588. No dose conversion or lot validation.

Methods > In vivo calcium imaging (S61, S62, S64, S65); Figure 4 legend (S94, S95, S97, S98)

intracellular Ca2+, measured using GCaMP3.0, in 0104-DA neurons: intracellular Ca2+, measured using GCaMP3.0, in 0104-DA neurons; comparator: 5 mM OA; OA-evoked response (red trace) — Figure 4 legend (S94, S95)

Mianserin 2.45 mM · Methods > In vivo calcium imaging (S64, S65); Figure 4 legend (S95)

Mianserin and xenobiotic gene expression in worms

Animal study · N2 worms [1]

N2 worms received Mianserin hydrochloride in a design that also included FUDR. Treatment fully induced the xenobiotic response regardless of the reported treatment start time, compared with water-treated control animals.

Measured endpoints — not treatment concentrations
EndpointReported resultReference
Log-fold change of xenobiotic gene expression on day 10xenobiotic gene expression up to 1,000-fold[1]

Conditions shared by the study groups

Treatment course
on day 1 or day 5
Vehicle
water (solvent)
Study groups and reported outcomes
Group / doseComparatorObserved resultReference
Mianserin hydrochloride 50 µMcontrol animals treated with water on day 1mianserin fully induced the xenobiotic response by up to 1,000-fold irrespective of whether added on day 1 or day 5[1]
Mianserin hydrochloride 50 µM
Model: N2 worms
Reported limits: Not stated in the sentences used: route.
Methods and source locations

Compound reported in the paper: Mianserin hydrochloride; Compound label in the paper: Mianserin

Literature evidence for the named compound in the stated model; no Adooq product-use or lot-performance claim.

Results > Longevity mechanisms attenuate transcriptional drift-variance (S63); Materials and methods > RNA-sequencing (RNA-seq) transcriptional studies and data analysis (S294, S297); Figure 2. legend (S369); Figure 2—figure supplement 2. legend (S406)

Log-fold change of xenobiotic gene expression on day 10: Log-fold change of xenobiotic gene expression on day 10; comparator: control animals treated with water on day 1 — Results > Longevity mechanisms attenuate transcriptional drift-variance (S63); Figure 2. legend (S369)

Mianserin hydrochloride 50 µM · Results > Longevity mechanisms attenuate transcriptional drift-variance (S63); Materials and methods > RNA-sequencing (RNA-seq) transcriptional studies and data analysis (S297); Figure 2. legend (S369)

Specifications

Manufacturer Adooq Bioscience
Actions Antagonist
CAS Number 21535-47-7
Applications 5-HT2/5-HT1 antagonist
Formula C18H20N2.HCl
Molecular Weight 300.83
Synonyms Bolvidon; Norval; Tolvon
SMILES
CN1CCN2C(C1)C3=CC=CC=C3CC4=CC=CC=C42.Cl

Storage & Solubility

In Vitro Solubility

Reported Solubility

SolventReported Solubility
DMSO 53 mg/mL (176.17 mM)
Water 27 mg/mL (89.75 mM)
Ethanol 19 mg/mL (63.15 mM)

Preparing Stock Solutions

Stock preparation is unavailable for this product molecular weight.

Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.

Storage

Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.

Research References

  1. [1] Rangaraju S, Solis GM, Thompson RC, et al. Suppression of transcriptional drift extends C. elegans lifespan by postponing the onset of mortality. Elife (2015). PMID: 26623667 DOI: 10.7554/eLife.08833 Source material
  2. [2] Mizunami M, Unoki S, Mori Y, et al. Roles of octopaminergic and dopaminergic neurons in appetitive and aversive memory recall in an insect. BMC Biol (2009). PMID: 19653886 DOI: 10.1186/1741-7007-7-46 Source material
  3. [3] Burke CJ, Huetteroth W, Owald D, et al. Layered reward signalling through octopamine and dopamine in Drosophila. Nature (2012). PMID: 23103875 DOI: 10.1038/nature11614 Source material

Added to your cart

View Cart Checkout
Loading...